相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System
Takashi Komori
LABORATORY INVESTIGATION (2022)
Rates and Patterns of Clonal Oncogenic Mutations in the Normal Human Brain
Javier Ganz et al.
CANCER DISCOVERY (2022)
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Ying Qing et al.
MOLECULAR CELL (2021)
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states
Ronan Chaligne et al.
NATURE GENETICS (2021)
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
C. Mircea S. Tesileanu et al.
ACTA NEUROPATHOLOGICA (2021)
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Michael Platten et al.
NATURE (2021)
The implications of IDH mutations for cancer development and therapy
Christopher J. Pirozzi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
D-2-Hydroxyglutarate in Glioma Biology
Fu-Ju Chou et al.
CELLS (2021)
Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma
Balazs Murnyak et al.
CELLS (2021)
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2020)
Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential
Patricia D. B. Tiburcio et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
The Glioma Stem Cell Model in the Era of Single-Cell Genomics
Mario L. Suva et al.
CANCER CELL (2020)
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature
Victor M. Lu et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma
Ingo K. Mellinghoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Epigenomic Reprogramming as a Driver of Malignant Glioma
Richard E. Phillips et al.
CANCER CELL (2020)
Histone H3.3G34-Mutant Intemeuron Progenitors Co-opt PDGFRA for Gliomagenesis
Carol C. L. Chen et al.
CELL (2020)
Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress
Krissie Lenting et al.
FASEB JOURNAL (2019)
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response
Felipe J. Nunez et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
H. Binder et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Friend or foe-IDH1 mutations in glioma 10 years on
L. Eric Huang
CARCINOGENESIS (2019)
CDKN2A HOMOZYGOUS DELETION IS A STRONG ADVERSE PROGNOSIS FACTOR IN DIFFUSE MALIGNANT IDHMUTANT GLIOMAS
R. Appay et al.
NEURO-ONCOLOGY (2019)
Novel IDH1-Targeted Glioma Therapies
Georg Karpel-Massler et al.
CNS DRUGS (2019)
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
Kay Ka-Wai Li et al.
NEURO-ONCOLOGY ADVANCES (2019)
The somatic mutation landscape of the human body
Pablo E. Garcia-Nieto et al.
GENOME BIOLOGY (2019)
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
Mitsuaki Shirahata et al.
ACTA NEUROPATHOLOGICA (2018)
Biological Role and Therapeutic Potential of IDH Mutations in Cancer
Matthew S. Waitkus et al.
CANCER CELL (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Mutant IDH1 Promotes Glioma Formation In Vivo
Beatrice Philip et al.
CELL REPORTS (2018)
Functional requirement of a wild-type allele for mutant IDH1 to suppress anchorage-independent growth through redox homeostasis
Patricia D. B. Tiburcio et al.
ACTA NEUROPATHOLOGICA (2018)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression
Christopher J. Pirozzi et al.
MOLECULAR CANCER RESEARCH (2017)
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1
Tali Mazor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
Andrew S. Venteicher et al.
SCIENCE (2017)
Insulator dysfunction and oncogene activation in IDH mutant gliomas
William A. Flavahan et al.
NATURE (2016)
Integrated genomic characterization of IDH1-mutant glioma malignant progression
Hanwen Bai et al.
NATURE GENETICS (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis
Chiara Bardella et al.
CANCER CELL (2016)
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
Shigeo Ohba et al.
CANCER RESEARCH (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma
Itay Tirosh et al.
NATURE (2016)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice
Esra A. Akbay et al.
GENES & DEVELOPMENT (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki et al.
GENES & DEVELOPMENT (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria
Martijn Kranendijk et al.
SCIENCE (2010)
分享论文
